In contrast to the cytoplasmic expression of FGF2 in cancer cells, many (∼35%) myo-fibroblasts (activated PSCs (Apte et al, 1999)) expressed nuclear FGF2, as evident from co-localisation analysis (Supplementary Fig 1, Fig 1B). The gene discussed is FGF2; the disease is cancer.